U.S. Healthcare Services Stock News

NYSE:DD
NYSE:DDChemicals

Has The DuPont de Nemours (DD) Rally Left Limited Value After Portfolio Reshaping?

Wondering whether DuPont de Nemours at around US$47.71 is still offering value, or if most of the opportunity has already been priced in? This article is built to help you frame that question clearly. The stock has recorded returns of 1.2% over the past week, 5.3% over the past month, 16.7% year to date and 69.4% over the last year, which is likely to catch the eye of investors thinking about both growth potential and changing risk perceptions. Recent coverage has focused on DuPont de...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

Viavi Board Refresh Puts Governance In Focus After Strong Share Run

Viavi Solutions appointed Joanne Solomon as Audit Committee Chair. Doug Gilstrap joined the Corporate Development Committee as part of Viavi's board refreshment efforts. These changes reflect ongoing succession planning and governance updates at NasdaqGS:VIAV. For shareholders watching NasdaqGS:VIAV, these board moves come after a sharp share price run, with the stock up 12.3% over the past 30 days and 167.2% year to date. The current share price of $48.49 also sits against very large 1...
NYSE:BKSY
NYSE:BKSYProfessional Services

BlackSky Contract Renewal Extends Space Awareness While Valuation Signals Mixed Picture

BlackSky Technology (NYSE:BKSY) has secured a major multi-year renewal for next-generation non-Earth imagery services. The contract extends and expands the company’s role in real-time space domain awareness and on-orbit object monitoring. The award includes specialized mission planning software and AI-powered analytics tailored to non-Earth observation. For investors watching NYSE:BKSY, this contract arrives with the stock at a share price of $51.63 and a very large 1 year return,...
NasdaqGS:BNTX
NasdaqGS:BNTXBiotechs

BioNTech Board Expansion Signals Focus On Oncology Execution And Valuation Gap

BioNTech (NasdaqGS:BNTX) has expanded its Supervisory Board following major late stage oncology data announcements at ASCO 2026. Prof. Iris Löw-Friedrich and Dr. Susanne Schaffert have been elected, adding experience in clinical development, oncology, and international commercialization. The board changes are described as aligning with BioNTech’s push to advance multiple pivotal cancer trials and prepare for potential future product launches. BioNTech, known for its mRNA technology...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

What PayPal Holdings (PYPL)'s New Travel and WeChat Pay Features Mean for Shareholders

In recent weeks, The Tour Guy launched a PayPal-enabled “Reserve Now, Pay Later” feature for select tours, while PayPal users in the U.S. gained the ability to pay Chinese merchants via WeChat Pay’s QR-code network through Tencent’s TenPay Global platform. Together, these moves highlight PayPal’s push to power flexible travel bookings and cross-border spending, extending its payment infrastructure into high-traffic international tourism corridors. We’ll now examine how PayPal’s expanded...
NasdaqGS:ALKT
NasdaqGS:ALKTSoftware

The Bull Case For Alkami Technology (ALKT) Could Change Following Regional Banks’ Rapid MANTL Adoption – Learn Why

In May 2026, Alkami Technology announced that multiple regional banks, including Citizens Bank and FVSBank, adopted its MANTL onboarding and account opening solutions to modernize and automate deposit account opening across digital and branch channels. By enabling these banks to automate more than 85% of application decisions and sharply cut account opening times, MANTL highlights Alkami’s role in reshaping how smaller institutions deliver faster, compliance-focused digital banking...
NYSE:HR
NYSE:HRHealth Care REITs

How a New US$400 Million Delayed Draw Term Loan Will Impact Healthcare Realty Trust (HR) Investors

Earlier this month, Healthcare Realty Holdings, L.P. entered into a US$400.0 million senior unsecured delayed draw term loan facility maturing in May 2029, with flexible SOFR- or base rate-linked pricing, an accordion option of up to US$100.0 million, and no mandatory amortization. The ability to draw this capital over a year, prepay without penalty, and operate under customary covenants highlights lender confidence in Healthcare Realty Trust’s credit profile and balance sheet...
NasdaqGS:MRVL
NasdaqGS:MRVLSemiconductor

Marvell Technology (MRVL) Thin Q1 EPS Raises Questions For Bullish Profitability Narrative

Marvell Technology (MRVL) opened its Q1 2027 scorecard with revenue of US$2.4 billion and basic EPS of US$0.04, alongside net income of US$34.5 million, giving investors a clean read on how the new fiscal year is starting. Over the past six quarters, revenue has moved from US$1.8 billion in Q4 2025 to US$1.9 billion in Q1 2026 and then to US$2.4 billion in Q1 2027. Basic EPS has ranged from US$0.23 to US$2.22 before landing at US$0.04 this quarter, a pattern that puts the focus squarely on...
NasdaqGM:ATAI
NasdaqGM:ATAIPharmaceuticals

AtaiBeckley Grant Program Links Mental Health Impact With Investor Considerations

AtaiBeckley, listed as NasdaqGM:ATAI, has launched a Patient Impact Grant Program focused on supporting mental health nonprofits. The program is designed to fund community projects, education initiatives, and research that target improved mental health outcomes. Grants will be reviewed externally and involve collaboration with established mental health organizations. For investors tracking NasdaqGM:ATAI, this move adds a new dimension to how the company engages with the mental health sector...
NYSE:MPC
NYSE:MPCOil and Gas

Is It Too Late To Consider Marathon Petroleum (MPC) After Its 60% One Year Surge?

If you are wondering whether Marathon Petroleum at US$251.33 is still offering value or starting to look stretched, the headline numbers only tell part of the story. The stock has posted returns of 1.2% over the past 7 days, 8.1% over 30 days, 52.2% year to date and 60.2% over the last year, which naturally raises questions about how much of this is already reflected in the current price. Recent attention on large integrated refiners and fuels infrastructure companies has kept Marathon...
NasdaqGS:CTAS
NasdaqGS:CTASCommercial Services

Has The Pullback In Cintas (CTAS) Opened A Fresh Valuation Opportunity?

If you are wondering whether Cintas stock still justifies its price tag, the key question is how its current market value compares with what the underlying business might reasonably be worth. The share price recently closed at US$173.06, with returns that rose 0.4% over the last 7 days but declined 0.7% over 30 days, 6.4% year to date, and 22.3% over 1 year. The 3 year and 5 year returns sit at 49.3% and 106.7% respectively. Recent coverage has focused on Cintas as a long term compounder in...
NYSE:RAMP
NYSE:RAMPSoftware

A Look At LiveRamp (RAMP) Valuation After Recent Share Price Momentum

LiveRamp Holdings (RAMP) has drawn fresh attention after a recent swing in performance, with the stock up about 26% over the past month and roughly 38% in the past 3 months. See our latest analysis for LiveRamp Holdings. That recent surge sits alongside a 37.1% year to date share price return and a 15.2% total shareholder return over 1 year. This suggests momentum has been building after a slower longer term record that includes a 23.4% total shareholder return decline over 5 years. If...
NasdaqGS:AMBA
NasdaqGS:AMBASemiconductor

Ambarella (AMBA) Is Up 9.8% After Securing US$800 Million Hanwha Edge AI Deal And Q2 Guide

On May 28, 2026, Ambarella, Inc. reported first-quarter sales of US$100.36 million and a net loss of US$18.09 million, issued second-quarter revenue guidance of US$105.0–111.0 million, and Hanwha Group announced a long-term edge AI technology agreement with Ambarella valued at over US$800 million across more than ten years. This multi-generational partnership, spanning video security, robotics, industrial automation, and life sciences, positions Ambarella’s CVflow-based edge AI platform and...
NasdaqGM:SYM
NasdaqGM:SYMMachinery

Assessing Symbotic (SYM) Valuation After A Sharp Single Day Share Price Drop

Why Symbotic stock is drawing fresh attention Symbotic (SYM) is back on many watchlists after a sharp single day share price drop of about 9%, prompting investors to reassess how the warehouse automation specialist is currently being valued. See our latest analysis for Symbotic. That one day share price decline sits within a wider pullback, with Symbotic’s share price down 14.49% over 30 days and 24.76% year to date. However, the 1 year total shareholder return is 68.66%, so recent momentum...
NYSE:NRP
NYSE:NRPOil and Gas

Assessing Natural Resource Partners (NRP) Valuation After Recent Share Price Pullback

Why Natural Resource Partners Is On Investors’ Radar Natural Resource Partners (NRP) has drawn investor attention after recent trading saw the stock close at $105.50. This has prompted a closer look at how its mineral rights and soda ash businesses support its current valuation. See our latest analysis for Natural Resource Partners. Recent trading has been mixed, with the share price return down about 10% over the past month and 13% over the past quarter. By contrast, the year-to-date share...
NYSE:ABT
NYSE:ABTMedical Equipment

A Look At Abbott Laboratories (ABT) Valuation After New Approvals For Libre Duo And Ultreon 3.0

Abbott Laboratories (ABT) is back in focus after winning European clearance for its Libre Duo glucose ketone sensors and securing approval for its Ultreon 3.0 AI coronary imaging software. See our latest analysis for Abbott Laboratories. Despite the fresh regulatory wins for Libre Duo and Ultreon 3.0, Abbott Laboratories’ share price is down 30.5% year to date and the 1 year total shareholder return has declined 33.7%. This suggests recent momentum has faded even as product news keeps...
NYSE:DY
NYSE:DYConstruction

Dycom Industries (DY) Q1 Revenue Beat Tests Bullish Margin Expansion Narrative

Q1 2027 earnings snapshot Dycom Industries (DY) opened its Q1 2027 scorecard with revenue of about US$2.0b and basic EPS of US$3.05, setting a clear marker for how the current trading price of US$535.20 lines up with the underlying business. Over the past year, revenue has moved from US$1.26b in Q1 2026 to US$2.0b in Q1 2027, while quarterly basic EPS shifted from US$2.11 to US$3.05. This sits against a backdrop of trailing twelve month basic EPS of US$10.62 on revenue of roughly US$6.3b,...
NYSE:ABR
NYSE:ABRMortgage REITs

Assessing Arbor Realty Trust (ABR) Valuation After CLO Redemption And Improved Repurchase Financing Terms

Arbor Realty Trust (ABR) recently redeemed $787.0 million of legacy CLO 17 notes and moved about $1.21 billion of assets into repurchase facilities with JPMorgan, securing better terms and creating roughly $132.3 million of liquidity. See our latest analysis for Arbor Realty Trust. Despite the refinancing progress, the stock has had a weak run, with a 30-day share price return down 29.9% and a 1-year total shareholder return down 35.1%. This indicates that momentum has been soft even as...
NYSE:ELAN
NYSE:ELANPharmaceuticals

A Look At Elanco Animal Health (ELAN) Valuation As Befrena Launch Expands Pet Dermatology Portfolio

Elanco Animal Health (ELAN) has kicked off a phased launch of Befrena, an anti IL 31 monoclonal antibody injection for canine allergic and atopic dermatitis, giving investors fresh information on its pet dermatology portfolio. See our latest analysis for Elanco Animal Health. Elanco's recent Befrena launch comes as momentum in the stock has picked up in the short term, with a 7 day share price return of 12.48% and a 1 month share price return of 8.26%, even though the 3 month share price...
NYSE:SYY
NYSE:SYYConsumer Retailing

A Look At Sysco (SYY) Valuation After Its 2026 Newsweek AI Impact Award Recognition

Sysco (SYY) recently attracted fresh attention after receiving a 2026 Newsweek AI Impact Award for its company-wide artificial intelligence program, raising questions about how this digital shift might factor into the stock’s long term story. See our latest analysis for Sysco. At a share price of $75.92, Sysco has seen its 30 day share price return rise 3.48%, even though the 90 day share price return has fallen 16.72%. The 1 year total shareholder return of 8.37% points to steadier long term...
NYSE:PB
NYSE:PBBanks

Is Prosperity Bancshares (PB) Offering Value After Recent Stable Share Performance?

Wondering if Prosperity Bancshares at around US$69.31 a share reflects good value? This article walks through what the current price might be implying about the stock. The stock has been fairly steady lately, with a 0.3% return over the last 7 days, a slight 0.2% decline over 30 days, a 0.5% decline year to date, and a 2.3% return over the last year, alongside longer term returns of 31.9% over 3 years and 5.9% over 5 years. Recent coverage has focused on how regional banks are balancing...
NYSE:BBW
NYSE:BBWSpecialty Retail

Build A Bear Workshop Q1 Net Margin Holds Near 10.5% And Tests Bullish Growth Narratives

Build-A-Bear Workshop (BBW) opened Q1 2027 with revenue of US$125.3 million, Basic EPS of US$1.45 and net income of US$18.3 million, while trailing 12 month figures show revenue of US$526.7 million, Basic EPS of US$4.27 and net income of US$55.2 million. This gives investors a clear read on both the latest quarter and the broader run rate. Over the past six reported quarters, the company has seen quarterly revenue move between US$122.7 million and US$154.5 million and Basic EPS range from...
NasdaqGS:CRDO
NasdaqGS:CRDOSemiconductor

Credo Expands AI Data Center Reach With DustPhotonics Photonics Deal

Credo Technology Group Holding (NasdaqGS:CRDO) has completed its acquisition of DustPhotonics. The deal brings silicon photonics and photonic integrated circuit technology into Credo's optical connectivity portfolio. The combined platform is intended to serve next generation optical links for AI and cloud data center infrastructure. Credo's share price stands at $222.35, with the stock up 15.0% over the past week and 34.0% over the past month. Over the past year the return is 248.3%, and...
NYSE:MGM
NYSE:MGMHospitality

MGM Launches Drink Las Vegas Festival As Stock Trades Below Targets

MGM Resorts International (NYSE:MGM) has launched Drink Las Vegas, a new four day culinary and beverage festival across its Las Vegas Strip properties. The inaugural event features leading chefs, mixologists, and VIP experiences, spotlighting MGM's focus on immersive hospitality offerings. Drink Las Vegas is designed to position Las Vegas as a premier global destination for high end food and beverage experiences. MGM Resorts International enters this news cycle with its stock at $42.93 and...